Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Genome-Wide Scan For Quantitative Trait Loci of Serum Bilirubin - A Framingham Study

NCT00340509 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT00340509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00340509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Genome-Wide Scan For Quantitative Trait Loci of Serum Bilirubin - A Framingham Study
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Observational
Overall status
Completed
Start date
October 26, 2001
Completion date
July 23, 2013
Enrollment
1,888 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetics